跳至主要内容
临床试验/NCT00002270
NCT00002270已完成不适用

A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection

University of Miami1 个研究点 分布在 1 个国家开始时间: 2001年8月31日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
试验地点
1

研究概览

简要总结

To study the effectiveness of alpha interferon (IFN-A2b) and zidovudine (AZT) in treating progressive multifocal leukoencephalopathy (PML) as a complication of HIV-1 infection.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients must have:
  • •HIV seropositivity by both ELISA and Western blot.
  • •Biopsy proven progressive multifocal leukoencephalopathy (PML).

排除标准

  • •Co-existing Condition:
  • •Patients with the following conditions or symptoms are excluded:
  • •Intolerant to interferon.
  • •Prior or concomitant central nervous system disease (CNS) such as toxoplasmosis, multiple sclerosis (MS), or neurosyphilis.
  • •Patients with the following are excluded:
  • •Intolerant to interferon.
  • •Prior or concomitant central nervous system disease (CNS) such as toxoplasmosis, multiple sclerosis (MS), or neurosyphilis.
  • •Prior Medication:
  • •Patients receiving interferon for other reasons.

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验